How were new medicines discovered? (Q29616641)

title

How were new medicines discovered? (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21701501

30 April 2017

1 reference

1 reference

pharmacological phenomena

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21701501

5 December 2024

drug discovery

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21701501

5 December 2024

targeted therapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21701501

5 December 2024

adverse drug reaction

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21701501

5 December 2024

author name string

David C. Swinney

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21701501

5 December 2024

Jason Anthony

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21701501

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21701501

5 December 2024

language of work or name

1 reference

30 April 2017

publication date

24 June 2011

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21701501

full work available at URL

30 April 2017

http://www.nature.com/articles/nrd3480.pdf

file format

Portable Document Format

1 reference

http://www.nature.com/articles/nrd3480

5 December 2024

1 reference

Nature Reviews Drug Discovery

5 December 2024

published in

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21701501

30 April 2017

volume

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21701501

30 April 2017

issue

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21701501

30 April 2017

page(s)

507-19

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21701501

Lessons from 60 years of pharmaceutical innovation

30 April 2017

cites work

1 reference

How to improve R&D productivity: the pharmaceutical industry's grand challenge

31 March 2020

1 reference

31 March 2020

1 reference

Drugs, their targets and the nature and number of drug targets

31 March 2020

1 reference

How many drug targets are there?

31 March 2020

1 reference

Systems and integrative biology as alternative guises for pharmacology: prime time for an iPharm concept?

31 March 2020

1 reference

Rethinking target discovery in polygenic diseases.

31 March 2020

1 reference

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

31 March 2020

1 reference

Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery

31 March 2020

1 reference

Biochemical mechanisms of drug action: what does it take for success?

31 March 2020

1 reference

Biochemical mechanisms of New Molecular Entities (NMEs) approved by United States FDA during 2001-2004: mechanisms leading to optimal efficacy and safety

31 March 2020

1 reference

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

31 March 2020

1 reference

Molecular basis of agonism and antagonism in the oestrogen receptor

31 March 2020

1 reference

The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein

31 March 2020

1 reference

Drug-target residence time and its implications for lead optimization

31 March 2020

1 reference

Residence time of receptor-ligand complexes and its effect on biological function

31 March 2020

1 reference

Drug-target residence time: critical information for lead optimization.

31 March 2020

1 reference

Strategies for discovering and derisking covalent, irreversible enzyme inhibitors

31 March 2020

1 reference

Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

31 March 2020

1 reference

Pathologically activated therapeutics for neuroprotection

31 March 2020

1 reference

Allosteric receptors: from electric organ to cognition

31 March 2020

1 reference

Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

31 March 2020

1 reference

Using lidocaine and benzocaine to link sodium channel molecular conformations to state-dependent antiarrhythmic drug affinity

31 March 2020

1 reference

The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning

31 March 2020

1 reference

Misconceptions about calcimimetics

31 March 2020

1 reference

Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461

31 March 2020

1 reference

A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia

31 March 2020

1 reference

Natural products as sources of new drugs over the last 25 years

31 March 2020

1 reference

Therapeutic strategies based on glucagon-like peptide 1.

31 March 2020

1 reference

Rational design of potent sialidase-based inhibitors of influenza virus replication

31 March 2020

1 reference

Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity

31 March 2020

1 reference

New thrombopoietic growth factors

31 March 2020

1 reference

New therapeutics that antagonize endothelin: promises and frustrations

31 March 2020

1 reference

Structure-based design of aliskiren, a novel orally effective renin inhibitor

31 March 2020

1 reference

Integrase inhibitors to treat HIV/AIDS.

31 March 2020

1 reference

HIV-1 integrase inhibitors that compete with the target DNA substrate define a unique strand transfer conformation for integrase

31 March 2020

1 reference

Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

31 March 2020

1 reference

Protein therapeutics: a summary and pharmacological classification

31 March 2020

1 reference

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

31 March 2020

1 reference

The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators

31 March 2020

1 reference

Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer

31 March 2020

1 reference

Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug

31 March 2020

1 reference

Conserved Binding Mode of Human β 2 Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray Crystallography

31 March 2020

1 reference

Cell signaling by receptor tyrosine kinases

31 March 2020

1 reference

Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade

31 March 2020

1 reference

Role of induced fit in enzyme specificity: a molecular forward/reverse switch

31 March 2020

1 reference

Vigilance and validation: Keys to success in RNAi screening

31 March 2020

1 reference

Transcript Profiling and RNA Interference as Tools To Identify Small Molecule Mechanisms and Therapeutic Potential

31 March 2020

1 reference

Impact of high-throughput screening in biomedical research

31 March 2020

1 reference

Phenotypic Screening Strategies for Neurodegenerative Diseases: A Pathway to Discover Novel Drug Candidates and Potential Disease Targets or Mechanisms

31 March 2020

1 reference

The beautiful cell: high-content screening in drug discovery

31 March 2020

1 reference

The odyssey of marine pharmaceuticals: a current pipeline perspective.

31 March 2020

1 reference

The biological activity of human CD20 monoclonal antibodies is linked to unique epitopes on CD20.

31 March 2020

1 reference

Biochemical characterization of desloratadine, a potent antagonist of the human histamine H(1) receptor

31 March 2020

1 reference

Tiotropium (Spiriva): mechanistical considerations and clinical profile in obstructive lung disease

31 March 2020

1 reference

Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans

31 March 2020

1 reference

Comparative pharmacodynamics and pharmacokinetics of candesartan and losartan in man

31 March 2020

1 reference

Raloxifene: Magic bullet for heart and bone?

31 March 2020

1 reference

Competitiveness in follow-on drug R&D: a race or imitation?

31 March 2020

1 reference

Probing the links between in vitro potency, ADMET and physicochemical parameters.

31 March 2020

1 reference

31 March 2020

1 reference

Inhibition of the immune response by rapamycin, a new antifungal antibiotic

31 March 2020

1 reference

In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin

31 March 2020

1 reference

Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists

31 March 2020

1 reference

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

31 March 2020

1 reference

Dopamine receptor agonists, partial agonists and psychostimulant addiction

31 March 2020

1 reference

Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation

31 March 2020

1 reference

Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections

31 March 2020

1 reference

Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections

31 March 2020

1 reference

Catching up on schizophrenia: natural history and neurobiology

31 March 2020

1 reference

7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist

31 March 2020

1 reference

Novel antipsychotic agents with dopamine autoreceptor agonist properties: synthesis and pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H)-quinolinone derivatives

31 March 2020

1 reference

Epigenetics in human disease and prospects for epigenetic therapy

31 March 2020

1 reference

Echinocandin inhibition of 1,3-β-D-glucan synthase from Candida albicans

31 March 2020

1 reference

Studies on 2-oxoquinoline derivatives as blood platelet aggregation inhibitors. I. Alkyl 4-(2-oxo-1,2,3,4-tetrahydro-6-quinolyloxy)butyrates and related compounds

31 March 2020

1 reference

Development of daptomycin for gram-positive infections

31 March 2020

1 reference

THE INACTIVATION OF THE VIRUS OF EPIDEMIC INFLUENZA BY SOAPS.

31 March 2020

1 reference

Inactivation of Lipid-Containing Viruses by Long-Chain Alcohols

31 March 2020

1 reference

Extreme Sensitivity of Enveloped Viruses, Including Herpes Simplex, to Long-Chain Unsaturated Monoglycerides and Alcohols

31 March 2020

1 reference

Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex

31 March 2020

1 reference

FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent

31 March 2020

1 reference

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

31 March 2020

1 reference

Mechanism of action of the oxazolidinone antibacterial agents

31 March 2020

1 reference

SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents

31 March 2020

1 reference

Basolateral localization of native ClC-2 chloride channels in absorptive intestinal epithelial cells and basolateral sorting encoded by a CBS-2 domain di-leucine motif.

31 March 2020

1 reference

Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data

31 March 2020

1 reference

THE ADAMANTYL GROUP IN MEDICINAL AGENTS. I. HYPOGLYCEMIC N-ARYLSULFONYL-N' -ADAMANTYLUREAS

31 March 2020

1 reference

Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels

31 March 2020

1 reference

Substrate reduction therapy: miglustat as a remedy for symptomatic patients with Gaucher disease type 1.

31 March 2020

1 reference

N-acylphenylalanines and related compounds. A new class of oral hypoglycemic agents

31 March 2020

1 reference

N-(cyclohexylcarbonyl)-D-phenylalanines and related compounds. A new class of oral hypoglycemic agents. 2

31 March 2020

1 reference

Mechanisms for T-cell selective cytotoxicity of arabinosylguanine

31 March 2020

1 reference

31 March 2020

1 reference

Interaction of (4-hydroxyphenyl)pyruvate dioxygenase with the specific inhibitor 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione

31 March 2020

1 reference

Structure of the ferrous form of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis in complex with the therapeutic herbicide, NTBC.

31 March 2020

1 reference

Ranolazine, a novel agent for chronic stable angina

31 March 2020

1 reference

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

31 March 2020

1 reference

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

31 March 2020

1 reference

Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties

31 March 2020

1 reference

An assessment of rufinamide as an anti-epileptic in comparison with other drugs in clinical development

31 March 2020

1 reference

Diverse mechanisms of antiepileptic drugs in the development pipeline

31 March 2020

1 reference

Green tea catechins for treatment of external genital warts

31 March 2020

1 reference

Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle

31 March 2020

1 reference

Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.

31 March 2020

1 reference

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug

31 March 2020

1 reference

Structural modification of the P2' position of 2,7-dialkyl-substituted 5(S)-amino-4(S)-hydroxy-8-phenyl-octanecarboxamides: the discovery of aliskiren, a potent nonpeptide human renin inhibitor active after once daily dosing in marmosets

31 March 2020

1 reference

Non-peptide arginine-vasopressin antagonists: the vaptans

31 March 2020

1 reference

HIV drug development: the next 25 years

31 March 2020

1 reference

Chemokine antagonists as therapeutics: focus on HIV-1.

31 March 2020

1 reference

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity

31 March 2020

1 reference

The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor

31 March 2020

1 reference

Regio and stereospecific synthesis of 11 beta-substituted 19-norsteroids. Influence of 11 beta-substitution on progesterone receptor affinity - (1)

31 March 2020

1 reference

Mifepristone (RU486): A review

31 March 2020

1 reference

The X-ray Structure of RU486 Bound to the Progesterone Receptor in a Destabilized Agonistic Conformation

31 March 2020

1 reference

Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin

31 March 2020

1 reference

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

31 March 2020

1 reference

Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection

31 March 2020

1 reference

Fresh from the pipeline: Ramelteon.

31 March 2020

1 reference

The biology of incretin hormones

31 March 2020

1 reference

31 March 2020

1 reference

Innovations and challenges in renal cancer: consensus statement from the first international conference

31 March 2020

1 reference

Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors

31 March 2020

1 reference

Strategies in the design of antiviral drugs

31 March 2020

1 reference

A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved?

31 March 2020

1 reference

Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience

31 March 2020

1 reference

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

31 March 2020

1 reference

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

31 March 2020

1 reference

The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency

31 March 2020

1 reference

Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency

31 March 2020

1 reference

Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria

31 March 2020

1 reference

Verteporfin: a milestone in opthalmology and photodynamic therapy

31 March 2020

1 reference

Neurokinin 1 receptor antagonists--current prospects

31 March 2020

1 reference

12 December 2020

Designing transient binding drugs: a new concept for drug discovery

1 reference

12 December 2020

Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors.

1 reference

12 December 2020

N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis.

1 reference

12 December 2020

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

1 reference

12 December 2020

Immunopharmacological studies on TBX, a new antiallergic drug (1). Inhibitory effects on passive cutaneous anaphylaxis in rats and guinea pigs

1 reference

12 December 2020

3-Sulfamoylmethyl-1,2-benzisoxazole, a new type of anticonvulsant drug. Pharmacological profile

1 reference

12 December 2020

From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug

1 reference

12 December 2020

Preliminary studies on a more effective phototoxic agent than hematoporphyrin

1 reference

12 December 2020

Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.

1 reference

12 December 2020

Molecular mechanisms of local anesthesia: a review

1 reference

12 December 2020

Purine nucleoside antimetabolites in development for the treatment of cancer.

1 reference

12 December 2020

Effects of the novel antipsychotic agent 7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro -2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland

1 reference

12 December 2020

A potent specific pure antiestrogen with clinical potential

1 reference

12 December 2020

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

1 reference

12 December 2020

Experimental Porphyric Neuropathy: A Preliminary Report

1 reference

12 December 2020

Pancreatic beta-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide

1 reference

12 December 2020

2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies

1 reference

12 December 2020

41

61

5790

RB Lichtner

2001

1 reference

Journal of Pharmacology and Experimental Therapeutics

5 December 2024

82

274

329

T Kikuchi

1995

1 reference

Journal of Pharmacology and Experimental Therapeutics

5 December 2024

84

277

137

T Inoue

1996

1 reference

5 December 2024

93

51

3867

AE Wakeling

1991

1 reference

5 December 2024

112

55

3352

CU Lambe

1995

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21701501

5 December 2024

Identifiers

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1047667098

0 references

1 reference

Consolidated OpenCitations Corpus – April 2017

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21701501

2 references

30 April 2017

Consolidated OpenCitations Corpus – April 2017